Gleason 6: should we keep calling it cancer?
Eva Compérat

Yes‼️ It’s cancer
✨People may die from GS 6
✨Up to 80% heterogeneous
✨We can not predict those who will progress
‼️Patient will be much more willing to be followed
@oncoalert.bsky.social
@drnataliagandur.bsky.social
@yukselurun.bsky.social

Gleason 6: should we keep calling it cancer?Roderick van den Bergh
No‼️ But we need surveillance
✨It doesn’t metastasize
✨14% upgrading
✨12-24% true progression
‼️Use of risk factors could estimate the risk of true cancer
@oncoalert.bsky.social @drnataliagandur.bsky.social @yukselurun.bsky.social

#PROSCA24 livestream starting with ADT and cardiovascular risk in #ProstateCancer. Suma Konety

‼️ADT increases CV risk => development of metabolic syndrome
‼️Control of blood pressure and cholesterol is mandatory = high genomic diversity

@oncoalert.bsky.social @drnataliagandur.bsky.social